New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - bisoprolol fumarate 10mg - film coated tablet - 10 mg - active: bisoprolol fumarate 10mg excipient: colloidal silicon dioxide croscarmellose sodium stear-o-wet m or ligamed mf bls-mb (magnesium stearate/sodium lauryl sulphate (94/6)) iron oxide red lactose microcrystalline cellulose opadry orange 40c83047 - treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - bisoprolol fumarate 2.5mg - film coated tablet - 2.5 mg - active: bisoprolol fumarate 2.5mg excipient: colloidal silicon dioxide croscarmellose sodium stear-o-wet m or ligamed mf bls-mb (magnesium stearate/sodium lauryl sulphate (94/6)) iron oxide red iron oxide yellow lactose microcrystalline cellulose opadry grey 40c57557 - treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - bisoprolol fumarate 5mg - film coated tablet - 5 mg - active: bisoprolol fumarate 5mg excipient: colloidal silicon dioxide croscarmellose sodium stear-o-wet m or ligamed mf bls-mb (magnesium stearate/sodium lauryl sulphate (94/6)) iron oxide yellow lactose microcrystalline cellulose opadry yellow 40c82321 - treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.

Ireland - English - HPRA (Health Products Regulatory Authority)

viatris limited - amlodipine besilate - tablet - dihydropyridine derivatives; amlodipine

Ireland - English - HPRA (Health Products Regulatory Authority)

viatris limited - amlodipine besilate - tablet - dihydropyridine derivatives; amlodipine

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - atenolol 100mg; atenolol 100mg - film coated tablet - 100 mg - active: atenolol 100mg excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium carbonate magnesium stearate maize starch purified talc sodium laurilsulfate sodium starch glycolate sunset yellow aluminium lake titanium dioxide active: atenolol 100mg excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium carbonate magnesium stearate maize starch purified talc purified water sodium laurilsulfate sodium starch glycolate titanium dioxide - control of hypertension.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - atenolol 50mg; atenolol 50mg - film coated tablet - 50 mg - active: atenolol 50mg excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium carbonate magnesium stearate maize starch purified talc sodium laurilsulfate sodium starch glycolate sunset yellow aluminium lake titanium dioxide active: atenolol 50mg excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium carbonate magnesium stearate maize starch purified talc purified water sodium laurilsulfate sodium starch glycolate titanium dioxide - control of hypertension.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - lamivudine 150mg; zidovudine 300mg - film coated tablet - active: lamivudine 150mg zidovudine 300mg excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry white propylene glycol purified water sodium starch glycolate - indicated for the treatment of hiv infected adults and adolescents over the age of 12 years, with progressive immunodeficiency (cd4+ count = < 500 cells/mm³).

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - lamivudine 150mg;  ;   - film coated tablet - 150 mg - active: lamivudine 150mg     excipient: magnesium stearate microcrystalline cellulose opadry white propylene glycol purified water sodium starch glycolate - lamuvidine in combination with other anti-retroviral agents is indicated for the treatment of hiv-infected adults and children.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - rosuvastatin calcium 10.396mg equivalent to rosuvastatin 10 mg - film coated tablet - 10 mg - active: rosuvastatin calcium 10.396mg equivalent to rosuvastatin 10 mg excipient: colloidal silicon dioxide crospovidone iron oxide red lactose monohydrate light magnesium oxide magnesium stearate microcrystalline cellulose opadry pink - rosuvastatin calcium is indicated to: · reduce elevated ldl-c, total cholesterol, triglycerides and to increase hdlcholesterol in patients with primary hypercholesterolemia (heterozygous familial and non familial) and mixed dyslipidaemia (fredrickson types iia and iib). rosuvastatin calcium also lowers apob, nonhdl-c, vldl-c, vldl-tg, the ldl-c/hdl-c, total c/hdl-c, nonhdl-c/hdl-c, apob/apoa-i ratios and increase apo-a-i in these populations. · treat isolated hypertriglyceridaemia (fredrickson type iv hyperlipidaemia). · reduce total cholesterol and ldl-c in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or alone if such treatments are unavailable.